A venture capital firm founded in 2020 and headquartered in the US participates in Pre-Seed and Seed stage funding rounds to tech and science focused companies. The firm typically allocates $1M USD per company and will either lead or participate in a syndicate, though they prefer to lead. The firm invests globally.
The firm invests in a wide range of sectors including, but not limited to, energy, robotics, life sciences, software services, education, and more. In terms of life sciences and healthcare, the firm is also agnostic and will look at therapeutics, medical devices, diagnostics, and digital health. If looking at medical devices, the firm prefers them to be AI and/or robotics driven. The firm does not look at single assets and rather prefers platform or technology driven assets. The firm is also indication-agnostic. Companies should be in development stages.
The firm requires a full-time team. The firm also will take a board observer seat.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment